Radiosensitization with carboplatin for patients with unresectable stage III non-small-cell lung cancer: A phase III trial of the cancer and leukemia group B and the eastern cooperative oncology group

Journal of Clinical Oncology

Volumn 17, Issue 1, 1999, Pages 4-11

  Clamon, Gerald ^a   Herndon, James ^a   Cooper, Robert ^a   Chang, Alex Y ^a   Rosenman, Julian ^a   Green, Mark R ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; VINBLASTINE;

ADULT; AGED; ANEMIA; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKEMIA; LUNG NON SMALL CELL CANCER; LUNG TOXICITY; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 0032947757     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.1999.17.1.4     Document Type: Article

References (26)

1. Dillman RO, Seagren SL, Propert KJ, et al: A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer. N Engl J Med 323:940-945, 1990
2. Dillman RO, Herndon J, Seagren SL, et al: Improved survival in stage III non-small-cell lung cancer: Seven year follow-up of Cancer and Leukemia Group B (CALGB) 8433 trial. J Natl Cancer Inst 88:1210-1215, 1996
3. Sause WT, Scott C, Taylor S, et al: Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer. J Natl Cancer Inst 87:198-205, 1995
4. Pritchard RS, Anthony SP: Chemotherapy plus radiotherapy compared with radiotherapy alone in the treatment of locally advanced, unresectable, non-small-cell lung cancer: A meta-analysis. Ann Intern Med 125:723-729, 1996
5. Morton RF, Jett JR, McGinnis WL, et al: Thoracic radiation therapy alone compared with combined chemoradiotherapy for locally unresectable non-small-cell lung cancer: A randomized, phase III trial. Ann Intern Med 115:681-686, 1991
6. Le Chevalier R, Arriagada R, Quoix E, et al: Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: First analysis of a randomized trial in 353 patients. J Natl Cancer Inst 83:417-423, 1991
7. Trovo MG, Minatel E, Veronesi A, et al: Combined radiotherapy and chemotherapy versus radiotherapy alone in locally advanced epidermoid bronchogenic carcinoma: A randomized study. Cancer 65:400-404, 1990
8. Clamon G, Herndon J, Eaton W, et al: A feasibility study of extended chemotherapy for locally advanced non-small-cell lung cancer: A phase II trial of Cancer and Leukemia Group B. Cancer Invest 12:273-282, 1994
9. Schaake-Koning C, Van Den Bogaert W, Dalesio O, et al: Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med 326:524-530, 1992
10. Schaake-Koning C, Maat B, Van Houtte P, et al: Radiotherapy combined with low dose cis-diammine dichloroplatinum (II) (CDDP) in inoperable nonmetastatic non-small-cell lung cancer (NSCLC): A randomized three-arm phase II study of the EORTC lung cancer and radiotherapy cooperative groups. Int J Radiat Oncol Biol Phys 19:967-972, 1990
11. Green S, Weiss GR: Southwest Oncology Group standard response criteria, endpoint definitions, and toxicity criteria. Invest New Drugs 10:239-253, 1992
12. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Soc 53:457-481, 1958
13. Peto R, Pike MC, Armitage P, et al: Design and analysis of randomized clinical trials requiring prolonged observation of each patient: II. Analysis and examples. Br J Cancer 35:1-39, 1977
14. Cox DR: Regression models and life-tables. J R Stat Soc 34:87-220, 1972
15. Yang L, Douple EB, O'Hara JA, et al: Production of DNA double-strand breaks by interactions between carboplatin and radiation: A potential mechanism for radioprotection. Radiat Res 143:309-315, 1995
16. Yang LX, Douple EB, Wang HJ: Irradiation enhances cellular uptake of carboplatin. Int J Radiat Oncol Biol Phys 33:641-646, 1995
17. Groen HJ, Sleijfer S, Meijer C, et al: Carboplatin- and cisplatin-induced potentiation of moderate-dose radiation cytotoxicity in human lung cancer cell lines. Br J Cancer 72:1406-1411, 1995
18. Aratani Y, Yoshiga K, Mizuuchi H, et al: Antitumor effect of carboplatin combined with radiation on tumors in mice. Anticancer Res 17:2535-2538, 1997
19. Wolf M, Goerg G, Goer K, et al: Carboplatin and simultaneous radiation in the treatment of stage III non-small-cell lung cancer. Oncology 49:71-77, 1992 (suppl 1)
20. Kunitoh H, Watanabe K, Nagatomo A, et al: Concurrent daily carboplatin and accelerated thoracic radiotherapy in locally advanced non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 37:103-109, 1997
21. Choy H, Akerley W, Safran H, et al: Paclitaxel plus carboplatin and concurrent radiation therapy for patients with locally advanced non-small-cell lung cancer. Semin Oncol 23:117-119, 1996 (suppl 16)
22. Rosell R, Gomez-Codina J, Camps C, et al: A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. N Engl J Med 330:153-158, 1994
23. Roth JA, Fosella F, Komaki R, et al: A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. J Natl Cancer Inst 86:673-680, 1994
24. Kreisman H, Lisbona A, Olson L, et al: Effect of radiologic stage III substage on nonsurgical therapy of non-small-cell lung cancer. Cancer 72:1588-1596, 1993
25. Curran WJ, Stafford PM: Lack of apparent difference in outcome between clinically staged IIIA and IIIB non-small-cell lung cancer treated with radiation therapy alone. J Clin Oncol 8:409-415, 1990
26. Bonomi P, Gale M, Rowland K, et al: Pretreatment prognostic factors in stage III non-small-cell lung cancer patients receiving combined modality treatment. Int J Radiat Oncol Biol Phys 20:247-252, 1991